Pyridine

Pyridine

SCHEMBL7922453

ClI.c1ccncc1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL31396433 0.91
Pyridine SCHEMBL6933426 0.88 TSHR (0.69)
Pyridine SCHEMBL27692838 0.87
Benzene SCHEMBL10751789 0.87 TSHR (1.00)
Pyridine SCHEMBL16 0.87
SCHEMBL3052767 0.87 TSHR (1.00)
Pyridine SCHEMBL9037865 0.87 TSHR (1.00)
Benzene SCHEMBL1261317 0.87 TSHR (1.00)
Pyridine SCHEMBL933604 0.87 TSHR (1.00)
Pyridine SCHEMBL180431 0.87 TSHR (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577267-B2 Pyrimidine compounds for use as MAP4K1 inhibitors GLENMARK SPECIALITY S.A. (CH) 2026-03-17 US disclosed
US-20250289830-A1 KRAS INHIBITORS ELI LILLY AND COMPANY 2025-09-18 US disclosed
US-12351591-B2 KRas inhibitors ELI LILLY AND COMPANY (US) 2025-07-08 US disclosed
EP-4574210-A2 KAPPA OPIOID RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED THERETO The Scripps Research Institute (US) 2025-06-25 EP disclosed
EP-4141001-B1 KAPPA OPIOID RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED THERETO SCRIPPS RESEARCH INST (US) 2025-03-05 EP disclosed
EP-4499233-A1 KRAS INHIBITORS Eli Lilly and Company (US) 2025-02-05 EP disclosed
CN-119095853-A KRAS inhibitors 伊莱利利公司 2024-12-06 CN disclosed
CN-119039220-A Synthesis method of chloroquine 上海应用技术大学 2024-11-29 CN disclosed
CN-118852002-A Synthesis method of piperaquine 上海应用技术大学 2024-10-29 CN disclosed
CN-118834167-A Synthesis method of hydroxychloroquine 上海应用技术大学 2024-10-25 CN disclosed
WO-2018170492-A1 KAPPA OPIOID RECEPTOR ANTAGONISTS AND PRODUCTS AND METHODS RELATED THERETO THE SCRIPPS RESEARCH INSTITUTE (US) 2018-09-20 WO disclosed
US-20180265475-A1 HALOGENATED QUINOLINE DERIVATIVES AS ANTIMICROBIAL AGENTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2018-09-20 US disclosed
US-9828486-B2 Halogenated polysaccharides MANNINGTON MILLS, INC. (US) 2017-11-28 US disclosed
WO-2017053696-A2 HALOGENATED QUINOLINE DERIVATIVES AS ANTIMICROBIAL AGENTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2017-03-30 WO disclosed
US-20160280804-A1 Halogenated Polysaccharides MANNINGTON MILLS, INC. (US) 2016-09-29 US disclosed
WO-2016113757-A1 NOVEL RECYCLABLE IODINATING AGENT AND ITS APPLICATIONS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-07-21 WO disclosed
US-6225465-B1 REACTING BENZOAZEPINE OR BENZODIAZEPINE DERIVATIVE WITH PROTECTED AMINE IN PRESENCE OF PALLADIUM CATALYST IN PRESENCE OF CARBON MONOXIDE, REMOVING PROTECTING GROUPS SMITHKLINE BEECHAM PLC (GB) 2001-05-01 US disclosed
EP-1019383-A2 PROCESS FOR THE AMINOCARBONYLATION OF BENZAZEPINES AND BENZODIAZEPINES SMITHKLINE BEECHAM PLC (GB) 2000-07-19 EP disclosed
CN-1214045-A Process for aminocarbonylation of benzazepines and benzodiazepines SMITHKLINE BEECHAM PLC (GB) 1999-04-14 CN disclosed
WO-1997024336-A2 PROCESS FOR THE AMINOCARBONYLATION OF BENZAZEPINES AND BENZODIAZEPINES SMITHKLINE BEECHAM PLC (GB) 1997-07-10 WO disclosed